| [1] |
Liu TS.Chemotherapy selsction through the process of gastric cancer[J].Zhonghua Wei Chang Wai Ke Za Zhi, 20 12,15(2):118-20.[刘天舒.胃癌发展过程中各阶段化疗药物及 方案的选择[J].中华胃肠外科杂志,2012,15(2):118-20.]
|
| [2] |
Boku N, Yamamoto S, Fukuda H, et al. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: randomised phase 3 study[J].Lancet Oncol,2009, 10 (11):1063-9.
|
| [3] |
Koizumi W, Narahara H, Hara T, et al.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase Ⅲ trial[J].Lancet Oncol,2008,9(3):215-21.
|
| [4] |
Liu B, Ying J, Luo C, et al.S-1 combined with oxaliplatin as first line chemothera-py for chinese advanced gastric cancer patients[J].Hepatogastroenterology,2012,59(114):649-53.
|
| [5] |
Koizumi W, Takiuchi H, Yamada Y, et al. Phase Ⅱstudy of oxaliplatin plus S-1 -as first-line treatment for advanced gastric cancer (G-SOX study) [J].Ann Oncol,2010,21(5):1001-5.
|
| [6] |
Kim GM, Jeung HC, Rha SY, et al.A randomized phase Ⅱtrial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer[J].Eur J Cancer,2012,48(4):518-26.
|
| [7] |
Wang X,Wang ML,Zhou LY,et al. Randomized phase Ⅱstudy comparing paclitaxel with S-1 vs.S-1 as first-line treatment in patients with advanced gastric cancer. [J].Clin Transl Oncol,2013,15(10): 836-42.
|
| [8] |
Ueda Y, Yamagishi H, Ichikawa D.Multicenter phase Ⅱstudy of weekly paclitaxel plus S-1 combination chemotherapy in patients with advancedgastric cancer. [J].Gastric Cancer,2010,13(3):149-54.
|
| [9] |
Fukushima M.Antitumor activity and function of S-1, a new oral tegafur-based formulation[J].Gan To Kagaku Ryoho,2006,33 (Suppl 1):19-26.
|
| [10] |
Cunningham D, Starling N, Rao S, et al.Capecitabine and oxaliplatin for advanced esophagogastric cancer[J].N Engl J Med, 20 08,358(1):36-46.
|
| [11] |
Kano Y, Akutsu M, Tsunoda S, et al. Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro[J].Br J Cancer,1996 ,74(5):704-10.
|
| [12] |
Park SH,Lee WK,Chung M,et al. Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase Ⅱtrial in combination with infusional 5-fluorouracil[J].Anticancer Drugs,2006,17(2):225-9.
|
| [13] |
Chon HJ,Rha SY,Im CK,et al.Docetaxel versus paclitaxel combined with 5-Fu and leucovorin in advanced gastric cancer: combined analysis of two phase Ⅱ trials [J].Cancer Res Treat,2009,41(4):19 6- 204.
|
| [14] |
Mochiki E, Ogata K, Ohno T,et al. Phase Ⅱ multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer[J].Br J Cancer,2012 ,107(1):31-6.
|
| [15] |
Huang DZ,Xiong JP,Ba Y,et al.A phase Ⅱ prospective randomized controlled trial of weekly paclitaxel combined with S-1 or fluorouracil for advanced gastric carcinoma[J].Zhonghua Zhong Liu Za Zhi,2012,34(11):865-8.[黄鼎智,熊建萍,巴一,等.紫杉醇 每周方案联合氟特嗪胶囊与氟尿嘧啶治疗晚期胃癌的Ⅱ期前 瞻性随机对照研究[J].中华肿瘤杂志,2012,34(11):865-8.]
|
下载:
